Skip to content
10-Q

Quarterly Report

60 DEGREES PHARMACEUTICALS, INC. SXTP SXTPW

0001554855-25-001009

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 4.1M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.47M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.38M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 202.97K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 185.86K sh
Capex Q2 2025 · Jun 30, 2025 $50K
Capex Q2 2025 · Jun 30, 2024 $90K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$3.05M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.33M
Short Term Investments Q2 2025 · Jun 30, 2025 $0
Short Term Investments Q2 2025 · Dec 31, 2024 $1.73M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.97M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.66M
Stockholders Equity Q2 2025 · Jun 30, 2025 $2.43M
Stockholders Equity Q2 2025 · Dec 31, 2024 $4.04M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.69M
Current Liabilities Q2 2025 · Dec 31, 2024 $1.66M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.84M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.8M
Current Assets Q2 2025 · Jun 30, 2025 $3.84M
Current Assets Q2 2025 · Dec 31, 2024 $5.39M
Total Assets Q2 2025 · Jun 30, 2025 $4.18M
Total Assets Q2 2025 · Dec 31, 2024 $5.76M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.25
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.79
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$21.12
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$21.41
Eps Basic Q2 2025 · Jun 30, 2025 −$1.25
Eps Basic Q2 2025 · Jun 30, 2025 −$2.79
Eps Basic restated Q2 2025 · Jun 30, 2024 −$21.12
Eps Basic restated Q2 2025 · Jun 30, 2024 −$21.41
Sga Expense Q2 2025 · Jun 30, 2025 $1.61M
Sga Expense Q2 2025 · Jun 30, 2025 $3.3M
Sga Expense Q2 2025 · Jun 30, 2024 $1.13M
Sga Expense Q2 2025 · Jun 30, 2024 $2.2M
Rd Expense Q2 2025 · Jun 30, 2025 $249.88K
Rd Expense Q2 2025 · Jun 30, 2025 $657.51K
Rd Expense Q2 2025 · Jun 30, 2024 $3.1M
Rd Expense Q2 2025 · Jun 30, 2024 $3.43M
Net Income Q2 2025 · Jun 30, 2025 −$1.73M
Net Income Q2 2025 · Jun 30, 2025 −$3.61M
Net Income Q2 2025 · Jun 30, 2024 −$4.17M
Net Income Q2 2025 · Jun 30, 2024 −$3.74M
Operating Income Q2 2025 · Jun 30, 2025 −$1.6M
Operating Income Q2 2025 · Jun 30, 2025 −$3.52M
Operating Income Q2 2025 · Jun 30, 2024 −$4.19M
Operating Income restated Q2 2025 · Jun 30, 2024 −$5.53M
Gross Profit Q2 2025 · Jun 30, 2025 $50.88K
Gross Profit Q2 2025 · Jun 30, 2025 $141.16K
Gross Profit Q2 2025 · Jun 30, 2024 $35.41K
Gross Profit restated Q2 2025 · Jun 30, 2024 $75.65K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $50.05K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $123.32K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $89.56K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $155K
Revenue Q2 2025 · Jun 30, 2025 $100.93K
Revenue Q2 2025 · Jun 30, 2025 $264.48K
Revenue Q2 2025 · Jun 30, 2024 $124.97K
Revenue restated Q2 2025 · Jun 30, 2024 $230.65K